Literature DB >> 21362519

Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening.

Costas G Hadjipanayis1, Huabei Jiang, David W Roberts, Lily Yang.   

Abstract

Optical imaging is an inexpensive, fast, and sensitive imaging approach for the noninvasive detection of human cancers in locations that are accessible by an optical imaging device. Light is used to probe cellular and molecular function in the context of cancer in the living body. Recent advances in the development of optical instrumentation make it possible to detect optical signals produced at a tissue depth of several centimeters. The optical signals can be endogenous contrasts that capture the heterogeneity and biological status of different tissues, including tumors, or extrinsic optical contrasts that selectively accumulate in tumors to be imaged after local or systemic delivery. The use of optical imaging is now being applied in the clinic and operating room for the localization and resection of malignant tumors in addition to screening for cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21362519      PMCID: PMC3061227          DOI: 10.1053/j.seminoncol.2010.11.008

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  77 in total

1.  Molecular imaging in cancer.

Authors:  Ralph Weissleder
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

2.  US-guided core breast biopsy: use and cost-effectiveness.

Authors:  L Liberman; T L Feng; D D Dershaw; E A Morris; A F Abramson
Journal:  Radiology       Date:  1998-09       Impact factor: 11.105

3.  Enhancement of unbound clearance of ICG by plasma proteins, demonstrated in human subjects and interpreted without assumption of facilitating structures.

Authors:  S Keiding; P Ott; L Bass
Journal:  J Hepatol       Date:  1993-11       Impact factor: 25.083

4.  Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.

Authors:  Dmitry I Daniltchenko; Claus R Riedl; Markus D Sachs; Frank Koenig; Kurosch L Daha; Heinz Pflueger; Stefan A Loening; Dietmar Schnorr
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

5.  Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report.

Authors:  Walter Stummer; Tobias Beck; Wolfgang Beyer; Jan Hendrik Mehrkens; Andreas Obermeier; Nima Etminan; Herbert Stepp; Jörg-Christian Tonn; Reinhold Baumgartner; Jochen Herms; Friedrich Wilhelm Kreth
Journal:  J Neurooncol       Date:  2007-11-23       Impact factor: 4.130

6.  In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice.

Authors:  Marcus-René Lisy; Annika Goermar; Claudia Thomas; Jutta Pauli; Ute Resch-Genger; Werner A Kaiser; Ingrid Hilger
Journal:  Radiology       Date:  2008-04-15       Impact factor: 11.105

7.  Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.

Authors:  Lakshmi Sampath; Sunkuk Kwon; Shi Ke; Wei Wang; Rachel Schiff; Michel E Mawad; Eva M Sevick-Muraca
Journal:  J Nucl Med       Date:  2007-09       Impact factor: 10.057

8.  Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging.

Authors:  Sang Bong Lee; Moinuddin Hassan; Robert Fisher; Oleg Chertov; Victor Chernomordik; Gabriela Kramer-Marek; Amir Gandjbakhche; Jacek Capala
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

9.  High-resolution imaging diagnosis and staging of bladder cancer: comparison between optical coherence tomography and high-frequency ultrasound.

Authors:  Zhijia Yuan; Zhenguo Wang; Rubin Pan; Jingxuan Liu; Harris Cohen; Yingtian Pan
Journal:  J Biomed Opt       Date:  2008 Sep-Oct       Impact factor: 3.170

10.  Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study.

Authors:  P Mĺkvy; H Messmann; J Regula; M Conio; M Pauer; C E Millson; A J MacRobert; S G Bown
Journal:  Neoplasma       Date:  1995       Impact factor: 2.575

View more
  30 in total

1.  Design considerations for targeted optical contrast agents.

Authors:  Jeong Heon Lee; Gwangli Park; Gloria H Hong; Jungmun Choi; Hak Soo Choi
Journal:  Quant Imaging Med Surg       Date:  2012-12

2.  Label-free intraoperative parathyroid localization with near-infrared autofluorescence imaging.

Authors:  Melanie A McWade; Constantine Paras; Lisa M White; John E Phay; Carmen C Solórzano; James T Broome; Anita Mahadevan-Jansen
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

Review 3.  Nanotechnology applications for glioblastoma.

Authors:  Edjah K Nduom; Alexandros Bouras; Milota Kaluzova; Costas G Hadjipanayis
Journal:  Neurosurg Clin N Am       Date:  2012-06-14       Impact factor: 2.509

4.  Intraoperative Near-infrared Imaging for Parathyroid Gland Identification by Auto-fluorescence: A Feasibility Study.

Authors:  Frederic De Leeuw; Ingrid Breuskin; Muriel Abbaci; Odile Casiraghi; Haïtham Mirghani; Aïcha Ben Lakhdar; Corinne Laplace-Builhé; Dana Hartl
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

5.  Characterizing the detection threshold for optical imaging in surgical oncology.

Authors:  Andrew C Prince; Aditi Jani; Melissa Korb; Kiranya E Tipirneni; Benjamin B Kasten; Eben L Rosenthal; Jason M Warram
Journal:  J Surg Oncol       Date:  2017-06-19       Impact factor: 3.454

6.  Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.

Authors:  Larissa Sweeny; Andrew Prince; Neel Patel; Lindsay S Moore; Eben L Rosenthal; Brian B Hughley; Jason M Warram
Journal:  Laryngoscope       Date:  2016-08-31       Impact factor: 3.325

7.  Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.

Authors:  Amanda Shanks Huynh; Woo Jin Chung; Hyun-Il Cho; Valerie E Moberg; Esteban Celis; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2012-11-08       Impact factor: 7.446

8.  Polychromatic in vivo imaging of multiple targets using visible and near infrared light.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Peter L Choyke
Journal:  Adv Drug Deliv Rev       Date:  2012-12-07       Impact factor: 15.470

9.  Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.

Authors:  Kristine E Day; Lauren N Beck; Nicholas L Deep; Joy Kovar; Kurt R Zinn; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2013-04-24       Impact factor: 3.325

10.  Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.

Authors:  Kristine E Day; Larissa Sweeny; Brian Kulbersh; Kurt R Zinn; Eben L Rosenthal
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.